First Trust Nasdaq Pharmaceuticals ETF is a ETF series of First Trust Exchange-Traded Fund VI (series S000053945). Net assets $29.2M as of 2026-03-31. Index fund.
Showing 15 of 102 holdings by value.
| Holding | Ticker | Value | % of fund |
|---|---|---|---|
| Johnson & Johnson | — | $2.2M | 745.08% |
| Johnson & Johnson | JNJ | $2.2M | 745.08% |
| Bristol-Myers Squibb Company | BMY | $2.1M | 736.36% |
| Bristol-Myers Squibb Company | — | $2.1M | 736.36% |
| Merck & Co., Inc | MRK | $2.1M | 735.67% |
| Merck & Co., Inc | — | $2.1M | 735.67% |
| AbbVie Inc. | ABBV | $2.1M | 709.68% |
| AbbVie Inc. | — | $2.1M | 709.68% |
| Eli Lilly & Co. | — | $1.9M | 662.04% |
| Eli Lilly & Co. | LLY | $1.9M | 662.04% |
| Pfizer Inc. | PFE | $1.1M | 384.51% |
| Pfizer Inc. | — | $1.1M | 384.51% |
| Regeneron Pharmaceuticals, Inc. | — | $1.1M | 374.20% |
| Regeneron Pharmaceuticals, Inc. | REGN | $1.1M | 374.20% |
| Biogen Inc | BIIB | $1.1M | 361.88% |
| Report date | Net assets |
|---|---|
| 2026-03-31 | $29.2M |
| 2025-12-31 | $21.4M |
| 2025-09-30 | $15.7M |
| 2025-06-30 | $14.1M |
| 2025-03-31 | $15.1M |
| 2024-12-31 | $14.8M |
| 2024-09-30 | $17.3M |
| 2024-06-30 | $20.4M |